Global Allergy Diagnostics Market

Global Allergy Diagnostics And Therapeutics Market Size - By Type, By Allergen, By Test Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2035

Published: Jul-2026	Report ID: HLCA2633	Pages: 1 - 250	Formats^*:
Category : Healthcare

According to SPER Market Research, the Global Allergy Diagnostics And Therapeutics Market is estimated to reach USD 98.35 billion by 2035 with a CAGR 10.24%.

Introduction and Overview

The report includes an in-depth analysis of the Global Allergy Diagnostics And Therapeutics Market, including market size and trends, product mix, Applications, and supplier analysis.

The global Allergy Diagnostics And Therapeutics Market was valued at USD 37.1 billion in 2025 and is expected to reach USD 98.35 billion by 2035, registering a CAGR of 10.24% during the forecast period. The allergy therapeutics market is driven by the increasing prevalence of allergic diseases, continuous technological advancements, growing adoption of immunotherapy, and the introduction of innovative treatment options. Rising environmental pollution, urbanization, and occupational exposure have contributed to a higher incidence of allergies, increasing the demand for effective therapies. Additionally, the expanding use of in vitro diagnostic (IVD) testing supports market growth due to its accuracy, cost-effectiveness, and minimally invasive nature. Ongoing advancements in laboratory automation, improved diagnostic technologies, and the availability of affordable testing solutions are expected to further enhance diagnosis rates and create significant growth opportunities for the allergy therapeutics market.

By Type:

The therapeutics segment held the largest market share due to its strong focus on managing and relieving allergic conditions. Among treatment options, epinephrine remains the preferred choice because of its rapid and effective response during severe allergic reactions, making it an essential emergency therapy. Meanwhile, the diagnostic segment is expected to witness the fastest growth, driven by the increasing need for accurate and early allergy detection. Advances in diagnostic technologies and the introduction of innovative testing solutions are supporting allergy research, improving patient safety, and enabling more precise identification of allergens for targeted treatment strategies.

By Allergen:

The inhaled allergies segment accounted for the largest market share, driven by the rising prevalence of respiratory allergies linked to increasing air pollution, industrialization, climate change, and greater exposure to indoor and outdoor allergens. Advancements in diagnostic technologies, along with improved healthcare awareness and wider access to allergy testing, are supporting earlier and more accurate diagnosis. Meanwhile, the drug allergies segment is expected to witness the fastest growth due to increasing awareness, improved treatment availability, and the growing incidence of allergic reactions associated with various medications, which can lead to serious health complications.

By Test Type:

The in vitro testing segment held the largest market share due to its high accuracy in detecting allergen-specific immunoglobulin E (IgE) and identifying allergen sensitization. Growing demand for faster, more precise, and patient-friendly diagnostic solutions is driving segment growth. Technological advancements, including microfluidics, biosensor-based platforms, lab-on-a-chip devices, artificial intelligence, and data analytics, are improving testing speed, accuracy, and personalized risk assessment. These innovations support point-of-care diagnostics, enhance treatment decisions, and encourage wider adoption of allergy testing, creating significant opportunities for market growth and the development of advanced diagnostic solutions.

Regional Insights:

North America held the largest share of the allergy diagnostics and therapeutics market due to its advanced healthcare infrastructure, high prevalence of allergic diseases, strong regulatory support, and significant investments in research and development. The region benefits from rapid adoption of innovative diagnostic technologies, biologic therapies, and personalized treatment approaches, supported by increasing clinical trials and favorable reimbursement policies. The U.S. remains a key contributor, driven by early diagnosis initiatives, advanced medical technologies, and continuous product approvals.

Europe is expected to witness substantial growth during the forecast period, supported by the rising burden of allergic disorders, increasing public awareness, and stringent regulatory standards. Strong healthcare systems, expanding access to advanced diagnostics and immunotherapies, and ongoing research activities continue to drive regional market growth.

Market Competitive Landscape:

The Global Allergy Diagnostics And Therapeutics Market is highly consolidated Some of the market key players are AbbVie, Inc., Alcon, bioMérieux, Danaher, F. Hoffmann-La Roche Ltd., GSK plc, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Siemens Healthcare GmbH.

Recent Developments:

In August 2025, Sanofi launched Allegra-D in India, a non-drowsy allergy medication combining an antihistamine and a nasal decongestant, approved for adults and children aged 12 years and above.
In October 2024, Astria Therapeutics entered a licensing agreement with Inchon’s Sciences to develop the OX40 portfolio, including STAR-0310 for atopic dermatitis and other allergic and immunological disorders.

Scope of the report:

Report Metric Details

Market size available for the years 2022-2035

Base year considered 2025

Forecast Period 2026-2035

Segments Covered By Type, By Allergen, By Test Type

Regions Covered North America, Latin America, Asia-Pacific,

Europe, and Middle East & Africa

Companies Covered AbbVie, Inc., Alcon, bioMérieux, Danaher, F. Hoffmann-La Roche Ltd., GSK plc, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Siemens Healthcare GmbH.

Key Topics Covered in the Report

Global Allergy Diagnostics And Therapeutics Market Size (FY’2022-FY’2035)
Overview of Global Allergy Diagnostics And Therapeutics Market
Segmentation of Global Allergy Diagnostics And Therapeutics Market by Type (Diagnostics, Therapeutics)
Segmentation of Global Allergy Diagnostics And Therapeutics Market by Allergen Type (Food, Inhaled, Drug, Other allergen types)
Segmentation of Global Allergy Diagnostics And Therapeutics Market by Test Type (In Vivo Tests, In Vitro Tests)
Statistical Snap of Global Allergy Diagnostics And Therapeutics Market
Expansion Analysis of Global Allergy Diagnostics And Therapeutics Market
Problems and Obstacles in Global Allergy Diagnostics And Therapeutics Market
Competitive Landscape in the Global Allergy Diagnostics And Therapeutics Market
Details on Current Investment in Global Allergy Diagnostics And Therapeutics Market
Competitive Analysis of Global Allergy Diagnostics And Therapeutics Market
Prominent Players in the Global Allergy Diagnostics And Therapeutics Market
SWOT Analysis of Global Allergy Diagnostics And Therapeutics Market
Global Allergy Diagnostics And Therapeutics Market Future Outlook and Projections (FY’2026-FY’2035)
Recommendations from Analyst

1. Introduction

1.1 Scope of the report
1.2 Market segment analysis

2. Research Methodology

2.1 Research data source

2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 SPER’s internal Database
2.1.4 Primary insight from KOL’s

2.2 Market size estimation

2.2.1 Top-down and Bottom-up approach

2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1 Driver, Restraint, Opportunity and Challenges analysis

4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

5. Market variable and outlook

5.1 SWOT Analysis

5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats

5.2 PESTEL Analysis

5.2.1 Political Landscape
5.2.2 Economic Landscape
5.2.3 Social Landscape
5.2.4 Technological Landscape
5.2.5 Environmental Landscape
5.2.6 Legal Landscape

5.3 PORTER’s Five Forces
5.4 Heat Map Analysis

6. Competitive Landscape

6.1. Global Allergy Diagnostics And Therapeutics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Allergy Diagnostics And Therapeutics Market

7. Global Allergy Diagnostics And Therapeutics Market, By Type, (USD Million) 2022-2035

7.1 Diagnostics
7.2 Therapeutics

8. Global Allergy Diagnostics And Therapeutics Market, By Allergen Type, (USD Million) 2022-2035

8.1 Food
8.2 Inhaled
8.3 Drug
8.4 Other allergen types

9. Global Allergy Diagnostics And Therapeutics Market, By Test Type, (USD Million) 2022-2035

9.1 In Vivo Tests
9.2 In Vitro Tests

10. Global Allergy Diagnostics And Therapeutics Market, (USD Million) 2022-2035

10.1 Global Allergy Diagnostics And Therapeutics Market Size and Market Share

11. Global Allergy Diagnostics And Therapeutics Market, By Region, (USD Million) 2022-2035

11.1 Asia-Pacific

11.1.1 Australia

11.1.2 China

11.1.3 India

11.1.4 Japan

11.1.5 South Korea

11.1.6 Rest of Asia-Pacific

11.2 Europe

11.2.1 France

11.2.2 Germany

11.2.3 Italy

11.2.4 Spain

11.2.5 United Kingdom

11.2.6 Rest of Europe

11.3 Middle East and Africa

11.3.1 Kingdom of Saudi Arabia

11.3.2 United Arab Emirates

11.3.3 Qatar

11.3.4 South Africa

11.3.5 Egypt

11.3.6 Morocco

11.3.7 Nigeria

11.3.8 Rest of Middle-East and Africa

11.4 North America

11.4.1 Canada

11.4.2 Mexico

11.4.3 United States

11.5 Latin America

11.5.1 Argentina

11.5.2 Brazil

11.5.3 Rest of America

12. Company Profile

12.1 AbbVie, Inc.
12.1.1 Company details
12.1.2 Financial outlook
12.1.3 Product summary
12.1.4 Recent developments
12.2 Alcon
12.2.1 Company details
12.2.2 Financial outlook
12.2.3 Product summary
12.2.4 Recent developments
12.3 bioMérieux
12.3.1 Company details
12.3.2 Financial outlook
12.3.3 Product summary
12.3.4 Recent developments
12.4 Danaher
12.4.1 Company details
12.4.2 Financial outlook
12.4.3 Product summary
12.4.4 Recent developments
12.5 F. Hoffmann-La Roche Ltd.
12.5.1 Company details
12.5.2 Financial outlook
12.5.3 Product summary
12.5.4 Recent developments
12.6 GSK plc
12.6.1 Company details
12.6.2 Financial outlook
12.6.3 Product summary
12.6.4 Recent developments
12.7 Merck & Co., Inc.
12.7.1 Company details
12.7.2 Financial outlook
12.7.3 Product summary
12.7.4 Recent developments
12.8 Pfizer, Inc.
12.8.1 Company details
12.8.2 Financial outlook
12.8.3 Product summary
12.8.4 Recent developments
12.9 Sanofi
12.9.1 Company details
12.9.2 Financial outlook
12.9.3 Product summary
12.9.4 Recent developments
12.10 Siemens Healthcare GmbH
12.10.1 Company details
12.10.2 Financial outlook
12.10.3 Product summary
12.10.4 Recent developments
12.11 Others

13. Conclusion

14. List Of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1